United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Report Summary

GlobalData’s new report, United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the United States Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for  Diabetes Care Devices  market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the United States Diabetes Care Devicesmarket.        
• Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Medtronic, Inc., Bayer HealthCare AG, Abbott Laboratories, Becton, Dickinson and Company  and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the United States Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction 11
2.1 What is This Report About? 11

3 Diabetes Care Devices In United States 12
3.1 Diabetes Care Devices, Market Segmentation 12
3.2 Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 13
3.3 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2010 14
3.4 Diabetes Care Devices Market, United States, Category Contribution (%), 2010 15
3.5 Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 22
3.6 Diabetes Care Devices, United States, Company share (2009-2010) 26

4 Glucose Monitoring In United States 28
4.1 Glucose Monitoring, Market Segmentation 28
4.2 Glucose Monitoring Market, United States, Revenue Mix ($m), 2010 29
4.3 Glucose Monitoring Market, United States, Segment Contribution (%), 2010 30
4.4 Glucose Monitoring Overall Revenue (2003-2017) 31
4.4.1 Blood Glucose Meters Revenue (2003-2017) 35
4.5 Glucose Monitoring Overall Volume (2003-2017) 39
4.5.1 Blood Glucose Meters Volume (2003-2017) 43
4.6 Glucose Monitoring Average Price (2003-2017) 47
4.7 Glucose Monitoring Distribution Share (2009-2010) 48
4.8 Glucose Monitoring, United States, Company share (2009-2010) 49

5 Insulin Delivery In United States 51
5.1 Insulin Delivery, Market Segmentation 51
5.2 Insulin Delivery Market, United States, Revenue Mix ($m), 2010 52
5.3 Insulin Delivery Market, United States, Segment Contribution (%), 2010 53
5.4 Insulin Delivery Overall Revenue (2003-2017) 54
5.4.1 Insulin Pens Revenue (2003-2017) 58
5.4.2 Insulin Pumps Revenue (2003-2017) 62
5.5 Insulin Delivery Overall Volume (2003-2017) 66
5.5.1 Insulin Pens Volume (2003-2017) 70
5.5.2 Insulin Pumps Volume (2003-2017) 74
5.6 Insulin Delivery Average Price (2003-2017) 78
5.7 Insulin Delivery Distribution Share (2009-2010) 80
5.8 Insulin Delivery, United States, Company share (2009-2010) 81

6 Overview of Key Companies in United States Diabetes Care Devices Market 83
6.1 LifeScan, Inc. 83
6.1.1 Company Overview 83
6.1.2 Share in the United States Diabetes Care Devices Market 83
6.2 Medtronic, Inc. 84
6.2.1 Company Overview 84
6.2.2 Share in the United States Diabetes Care Devices Market 84
6.3 F. Hoffmann-La Roche Ltd. 85
6.3.1 Company Overview 85
6.3.2 Share in the United States Diabetes Care Devices Market 85
6.4 Bayer HealthCare AG 86
6.4.1 Company Overview 86
6.4.2 Share in the United States Diabetes Care Devices Market 86
6.5 Abbott Laboratories 87
6.5.1 Company Overview 87
6.5.2 Share in the United States Diabetes Care Devices Market 87
6.6 Becton, Dickinson and Company 88
6.6.1 Company Overview 88
6.6.2 Share in the United States Diabetes Care Devices Market 88
6.7 Eli Lilly and Company 89
6.7.1 Company Overview 89
6.8 Animas Corporation 89
6.8.1 Company Overview 89
6.9 Novo Nordisk A/S 89
6.9.1 Company Overview 89
6.10 Sanofi 90
6.10.1 Company Overview 90
6.11 Insulet Corporation 90
6.11.1 Company Overview 90
6.12 NIPRO CORPORATION 91
6.12.1 Company Overview 91
6.13 ARKRAY, Inc. 91
6.13.1 Company Overview 91

7 Diabetes Care Devices Market Pipeline Products 92

8 Financial Deals Landscape 98
8.1 Acquisition 98
8.1.1 Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 98
8.1.2 Insulet Acquires Neighborhood Diabetes 99
8.1.3 Sanare Acquires Doctor Diabetic Supply 100
8.2 Partnerships 101
8.2.1 Roche Diagnostics Enters Into Distribution Agreement With DexCom 101
8.2.2 Roche Diagnostics Enters Into Research And Development Agreement With DexCom 102
8.2.3 CalAsia Pharmaceuticals Enters Into Co-Development Agreement With Evan Kantrowitz 103
8.2.4 Bayer HealthCare Diabetes Care Expands Partnership With Medtronic 104
8.2.5 PositiveID Enters Into Agreement With HMD BioMedical 105
8.2.6 Perrigo Enters Into Distribution Agreement With AgaMatrix 106
8.2.7 ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 107
8.2.8 Midatech Enters Into Joint Venture With MonoSol Rx 108

9 Recent Developments 109
9.1 Strategy And Business Planning 109
9.1.1 Oct 19, 2011: Abbott To Separate Into Two Leading Companies In Diversified Medical Products And Research-Based Pharmaceuticals 109
9.1.2 Oct 13, 2011: Unisense Establishes US Headquarter 110
9.1.3 May 05, 2011: Medtronic Opens New Distribution Center In Mira Loma, California 111
9.1.4 Mar 08, 2011: Medtronic Inaugurates New Regional Headquarters Building In Greater China 111
9.1.5 Feb 03, 2011: LHC Group Announces Home Health Joint Venture With Baptist Hospital In Pensacola, Florida 112
9.1.6 Jan 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes 112
9.2 Legal and Regulatory 113
9.2.1 Nov 22, 2011: Izard Nobel Announces Class Action Lawsuit Against Hospira 113
9.2.2 Jul 11, 2011: Retractable Technologies Announces Decision From United States Court of Appeals for the Federal Circuit 113
9.2.3 Jun 08, 2011: US District Court Rules In Favor Of Lilly In Amylin Litigation 114
9.2.4 May 25, 2011: Lilly Comments On Court Ruling In Amylin Litigation 114
9.2.5 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction 114
9.2.6 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic 115
9.2.7 Apr 07, 2011: J&J To Pay $70m To Settle Cases Brought By SEC And Criminal Authorities 115
9.3 Government and Public Interest 116
9.3.1 Oct 14, 2011: MannKind To Present At 18th Annual Newsmakers In BioTech Industry Conference 116
9.3.2 Sep 29, 2011: Research At UC Reveals Hormone Action That Could Lead To Treatments For Type 2 Diabetes 117
9.3.3 Sep 14, 2011: Medtronic Pledges Action In Advance of United Nations High Level Meeting On Noncommunicable Diseases 117
9.3.4 Sep 08, 2011: Sanmina-SCI Kenosha, Wisconsin Facility Receives ISO 13485 Certification For Medical Devices 118
9.3.5 Jul 14, 2011: Lilly And Argonne National Laboratory Announce $2m Upgrade To Lilly's Beamline Capabilities 118
9.3.6 Jun 29, 2011: Hospira Supports North Carolina's New Legislation Aimed At Reducing Healthcare-Associated Infections 119
9.3.7 Apr 08, 2011: MannKind Provides Regulatory Update 120
9.3.8 Mar 09, 2011: Medtronic Resolves FDA Warning Letters 120
9.3.9 Feb 25, 2011: Breastfeeding Babies Exposed To Diabetes In Utero Protects Against Childhood Obesity: Study 120
9.3.10 Jan 27, 2011: Guided Therapeutics Receives ISO Certification 121
9.3.11 Jan 27, 2011: China's Ministry Of Commerce Grants Clearance For Merger Of BMP Sunstone And sanofi-aventis Subsidiary 121
9.3.12 Dec 22, 2010: Abbott Recalls Certain Lots Of Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium, OptiumEZ And ReliOn Ultima Blood Glucose Test Strips In US And Puerto Rico 123
9.3.13 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 124
9.4 Product News 125
9.4.1 Oct 28, 2011: ARKRAY's GLUCOCARD Vital And 01 Blood Glucose Meters Are Listed On DoD Uniform Formulary 125
9.4.2 Jun 29, 2010: Medtronic Announces STAR 3 Trial Results Confirming MiniMed Paradigm REAL-Time System Achieves Better Glucose Control Than Daily Insulin Injections In Diabetic Patients 125
9.4.3 Jun 25, 2010: Medtronic Begins Enrollment In ASPIRE Pivotal Study Of MiniMed Paradigm x54 System 126
9.4.4 Mar 17, 2010: Medtronic Announces FDA Approval Of MiniMed Paradigm REAL-Time Revel System 127

10 Appendix 128
10.1 Definitions of Markets Covered in the Report 129
10.1.1 Diabetes Care Devices 129
10.2 Research Methodology 132
10.3 Secondary Research 132
10.4 Primary Research 133
10.5 Models 133
10.6 Forecasts 134
10.7 Expert Panels 134
10.8 GlobalData Consulting 134
10.9 Contact Us 135
10.10 Disclaimer 135

List of Tables

Table 1:Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 13
Table 2:Diabetes Care Devices Market, United States, Category Contribution (%), 2010 15
Table 3:Diabetes Care Devices, United States, Cross-Segment Analysis,2002-2016 17
Table 4:Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 19
Table 5:Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 21
Table 6:Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 22
Table 7:Diabetes Care Devices, United States, Category Volume (Units), Historic, 2003-2010 24
Table 8:Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2010-2017 25
Table 9:Diabetes Care Devices, United States, Company share by Revenue ($m), USD Actual, 2009-2010 27
Table 10:Glucose Monitoring Market, United States, Segment Contribution (%), 2010 30
Table 11:Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 32
Table 12:Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 34
Table 13:Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 36
Table 14:Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 38
Table 15:Glucose Monitoring, United States, Volume (Units) by Segment, Historic, 2003-2010 40
Table 16:Glucose Monitoring, United States, Volume (Units) by Segment, Forecast, 2010-2017 42
Table 17:Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 44
Table 18:Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 46
Table 19:Glucose Monitoring, United States, Average Price ($), Historic, 2003-2010 47
Table 20:Glucose Monitoring, United States, Average Price ($), Forecast, 2010-2017 47
Table 21:Glucose Monitoring, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 48
Table 22:Glucose Monitoring, United States, Company share by Revenue ($m), USD Actual 2009-2010 50
Table 23:Insulin Delivery Market, United States, Segment Contribution (%), 2010 53
Table 24:Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 55
Table 25:Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 57
Table 26:Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 59
Table 27:Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 61
Table 28:Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 63
Table 29:Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 65
Table 30:Insulin Delivery, United States, Volume (Units) by Segment, Historic, 2003-2010 67
Table 31:Insulin Delivery, United States, Volume (Units) by Segment, Forecast, 2010-2017 69
Table 32:Insulin Pens, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 71
Table 33:Insulin Pens, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 73
Table 34:Insulin Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 75
Table 35:Insulin Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 77
Table 36:Insulin Delivery, United States, Average Price ($), Historic, 2003-2010 78
Table 37:Insulin Delivery, United States, Average Price ($), Forecast, 2010-2017 79
Table 38:Insulin Delivery, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 80
Table 39:Insulin Delivery, United States, Company share by Revenue ($m), USD Actual 2009-2010 82
Table 40:Diabetes Care Devices Market Pipeline Products 92
Table 41:Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 98
Table 42:Insulet Acquires Neighborhood Diabetes 99
Table 43:Sanare Acquires Doctor Diabetic Supply 100
Table 44:Roche Diagnostics Enters Into Distribution Agreement With DexCom 101
Table 45:Roche Diagnostics Enters Into Research And Development Agreement With DexCom 102
Table 46:CalAsia Pharmaceuticals Enters Into Co-Development Agreement With Evan Kantrowitz 103
Table 47:Bayer HealthCare Diabetes Care Expands Partnership With Medtronic 104
Table 48:PositiveID Enters Into Agreement With HMD BioMedical 105
Table 49:Perrigo Enters Into Distribution Agreement With AgaMatrix 106
Table 50:ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 107
Table 51:Midatech Enters Into Joint Venture With MonoSol Rx 108

List of Figures

Figure 1:Diabetes Care Devices, Market Segmentation 12
Figure 2:Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 13
Figure 3:Diabetes Care Devices Market, United States, Revenue Mix ($m), 2010 14
Figure 4:Diabetes Care Devices Market, United States, Category Contribution (%), 2010 15
Figure 5:Diabetes Care Devices, United States, Cross-Segment Analysis,2003-2017 16
Figure 6:Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 18
Figure 7:Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 20
Figure 8:Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 22
Figure 9:Diabetes Care Devices, United States, Category Volume (Units), Historic, 2003-2010 23
Figure 10:Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2010-2017 25
Figure 11:Diabetes Care Devices, United States, Company share (%), 2010 26
Figure 12:Glucose Monitoring, Market Segmentation 28
Figure 13:Glucose Monitoring Market, United States, Revenue Mix ($m), 2010 29
Figure 14:Glucose Monitoring Market, United States, Segment Contribution (%), 2010 30
Figure 15:Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 31
Figure 16:Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 33
Figure 17:Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 35
Figure 18:Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 37
Figure 19:Glucose Monitoring, United States, Volume (Units) by Segment, Historic, 2003-2010 39
Figure 20:Glucose Monitoring, United States, Volume (Units) by Segment, Forecast, 2010-2017 41
Figure 21:Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 43
Figure 22:Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 45
Figure 23:Glucose Monitoring, United States, Company share (%), 2010 49
Figure 24:Insulin Delivery, Market Segmentation 51
Figure 25:Insulin Delivery Market, United States, Revenue Mix ($m), 2010 52
Figure 26:Insulin Delivery Market, United States, Segment Contribution (%), 2010 53
Figure 27:Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 54
Figure 28:Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 56
Figure 29:Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 58
Figure 30:Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 60
Figure 31:Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 62
Figure 32:Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 64
Figure 33:Insulin Delivery, United States, Volume (Units) by Segment, Historic, 2003-2010 66
Figure 34:Insulin Delivery, United States, Volume (Units) by Segment, Forecast, 2010-2017 68
Figure 35:Insulin Pens, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 70
Figure 36:Insulin Pens, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 72
Figure 37:Insulin Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 74
Figure 38:Insulin Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 76
Figure 39:Insulin Delivery, United States, Company share (%), 2010 81
Figure 40:LifeScan, Inc., Company Share (%),United States Diabetes Care Devices Market, 2010 83
Figure 41:Medtronic, Inc., Company Share (%),United States Diabetes Care Devices Market, 2010 84
Figure 42:F. Hoffmann-La Roche Ltd., Company Share (%),United States Diabetes Care Devices Market, 2010 85
Figure 43:Bayer HealthCare AG, Company Share (%),United States Diabetes Care Devices Market, 2010 86
Figure 44:Abbott Laboratories, Company Share (%),United States Diabetes Care Devices Market, 2010 87
Figure 45:Becton, Dickinson and Company, Company Share (%),United States Diabetes Care Devices Market, 2010 88